Idarubicin Injection 10 mg/10 mL (4)

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

idarubicin hydrochloride, Quantity: 1 mg/mL

Tilgjengelig fra:

Pfizer (Perth) Pty Ltd

Legemiddelform:

Injection, solution

Sammensetning:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Administreringsrute:

Intravenous, Intravenous Infusion

Enheter i pakken:

1 x 10 mL

Resept typen:

(S1) This Schedule is intentionally blank

Indikasjoner:

Zavedos is used to treat acute myeloid and lymphoid leukaemia (types of blood cancer) in adults and children. Zavedos may be administered as a monotherapy or as part of combination therapy (with cytarabine).

Produkt oppsummering:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Listed (Export Only)

Autorisasjon dato:

2023-03-03